Market Cap 2.23B
Revenue (ttm) 0.00
Net Income (ttm) -175.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 11.99
Profit Margin 0.00%
Debt to Equity Ratio 0.10
Volume 1,889,900
Avg Vol 1,930,276
Day's Range N/A - N/A
Shares Out 53.71M
Stochastic %K 18%
Beta -3.12
Analysts Strong Sell
Price Target $113.83

Company Profile

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was i...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 213 8444
Fax: 650 213 8383
Website: soleno.life
Address:
100 Marine Parkway, Suite 400, Redwood City, United States
VanRamirez937
VanRamirez937 Jan. 13 at 5:52 PM
$SLNO $AMT Strong infrastructure angle
0 · Reply
BioTechHealthX
BioTechHealthX Jan. 13 at 4:55 PM
$SLNO Soleno Therapeutics Inc (NASDAQ:SLNO) is focused on precision therapies for rare diseases. This article explains why SLNO’s long-term story might be more important than it looks. https://biotechhealthx.com/biotech-news/soleno-therapeutics-slno-might-be-building-something-bigger-than-most-investors-realize/
0 · Reply
Californiamaster
Californiamaster Jan. 13 at 3:31 PM
$SLNO damn
0 · Reply
CH_Expat
CH_Expat Jan. 13 at 3:29 PM
$SLNO For fairness: https://mordechaison.substack.com/p/soleno-q3-earnings-commentary-and - this guy is long in SLNO. Make of it what you want.
1 · Reply
Biocontrol
Biocontrol Jan. 13 at 3:09 PM
$SLNO I’m about to do what the kids call a yolo
0 · Reply
Baldchinese
Baldchinese Jan. 13 at 3:05 PM
$SLNO sub 40 what the actual fuck is going on here
0 · Reply
RandomInvestor777
RandomInvestor777 Jan. 13 at 3:04 PM
$SLNO What the fuck is all i can say.
0 · Reply
Biocontrol
Biocontrol Jan. 12 at 10:24 PM
$SLNO this is not fully-baked, but more or less how I’m thinking about things here. Interested in other opinions.
0 · Reply
RandomInvestor777
RandomInvestor777 Jan. 12 at 7:20 PM
$SLNO Year-end 2025 cash, cash equivalents and marketable securities were approximately $500 million, after the $100 million accelerated share repurchase program. maybe they can do a bigger buyback program?
1 · Reply
SableOrder
SableOrder Jan. 12 at 5:50 PM
$SLNO Strong tape when it trends, if it consolidates tight then a breakout can offer clean asymmetry
0 · Reply
Latest News on SLNO
Soleno Therapeutics, Inc. Investigated by the Portnoy Law Firm

Nov 12, 2025, 10:56 AM EST - 2 months ago

Soleno Therapeutics, Inc. Investigated by the Portnoy Law Firm


Soleno: Blockbuster Launch In Progress

Oct 11, 2025, 8:45 AM EDT - 3 months ago

Soleno: Blockbuster Launch In Progress


Soleno Therapeutics Announces VYKAT(TM) XR Launch

Apr 14, 2025, 7:00 AM EDT - 9 months ago

Soleno Therapeutics Announces VYKAT(TM) XR Launch


VanRamirez937
VanRamirez937 Jan. 13 at 5:52 PM
$SLNO $AMT Strong infrastructure angle
0 · Reply
BioTechHealthX
BioTechHealthX Jan. 13 at 4:55 PM
$SLNO Soleno Therapeutics Inc (NASDAQ:SLNO) is focused on precision therapies for rare diseases. This article explains why SLNO’s long-term story might be more important than it looks. https://biotechhealthx.com/biotech-news/soleno-therapeutics-slno-might-be-building-something-bigger-than-most-investors-realize/
0 · Reply
Californiamaster
Californiamaster Jan. 13 at 3:31 PM
$SLNO damn
0 · Reply
CH_Expat
CH_Expat Jan. 13 at 3:29 PM
$SLNO For fairness: https://mordechaison.substack.com/p/soleno-q3-earnings-commentary-and - this guy is long in SLNO. Make of it what you want.
1 · Reply
Biocontrol
Biocontrol Jan. 13 at 3:09 PM
$SLNO I’m about to do what the kids call a yolo
0 · Reply
Baldchinese
Baldchinese Jan. 13 at 3:05 PM
$SLNO sub 40 what the actual fuck is going on here
0 · Reply
RandomInvestor777
RandomInvestor777 Jan. 13 at 3:04 PM
$SLNO What the fuck is all i can say.
0 · Reply
Biocontrol
Biocontrol Jan. 12 at 10:24 PM
$SLNO this is not fully-baked, but more or less how I’m thinking about things here. Interested in other opinions.
0 · Reply
RandomInvestor777
RandomInvestor777 Jan. 12 at 7:20 PM
$SLNO Year-end 2025 cash, cash equivalents and marketable securities were approximately $500 million, after the $100 million accelerated share repurchase program. maybe they can do a bigger buyback program?
1 · Reply
SableOrder
SableOrder Jan. 12 at 5:50 PM
$SLNO Strong tape when it trends, if it consolidates tight then a breakout can offer clean asymmetry
0 · Reply
RandomInvestor777
RandomInvestor777 Jan. 12 at 3:48 PM
$SLNO Zero reason for this to be trading at this price, WTF is happening?
1 · Reply
nnnuuu
nnnuuu Jan. 12 at 3:34 PM
$SLNO trying to time the bottom will be fun, definitely looking here to double my position
3 · Reply
CH_Expat
CH_Expat Jan. 12 at 3:31 PM
$SLNO I know a nice little manipulation when I see one! Added 40.65 USD.
1 · Reply
Jrmartin2
Jrmartin2 Jan. 12 at 3:29 PM
$SLNO that was good news. Glad it wasn’t bad, it would be at 4 per share
0 · Reply
Biocontrol
Biocontrol Jan. 12 at 2:57 PM
$SLNO I’m pretty happy w this. Shows they are still enrolling new patients after initial bolus, and discontinuation is basically in line with trial adverse events. Both opposite of what the Scorpion report theorized. I think with the low discontinuation rate, they’ll continue to bring in new providers. We’ll see.
0 · Reply
Quantumup
Quantumup Jan. 12 at 2:29 PM
Stifel in a note to investors said: We think $SLNO's (Buy; $115 PT) pre-print is overall solid, meets what investors were largely hoping to see, and supports Vykat's blockbuster potential. $RYTM $AARD $BIIB Here's what else Stifel had to say:
0 · Reply
DonCorleone77
DonCorleone77 Jan. 12 at 2:24 PM
$WMT $SLNO $COF $JPM $ANF PRE-MARKET MOVERS: Currently Higher After Preliminary Earnings: - Soleno Therapeutics (SLNO) up 3.5% Currently Also Higher: - Day One Biopharmaceuticals (DAWN) up 20.9% after reporting preliminary Ojemda net product revenue - Sun Country Airlines (SNCY) up 13.6% after announcing a definitive merger agreement under which Allegiant (ALGT) will acquire Sun Country in a cash and stock transaction at an implied value of $18.89 per Sun Country share - Walmart (WMT) up 3.0% after announcing that it plans to launch a new experience that pairs Google's (GOOGL) Gemini with Walmart and Sam's Club's assortment Currently Lower After Preliminary Earnings: - Shake Shack (SHAK) down 2.5% Currently Lower After Trump's Proposal for 10% Cap on Credit Card Interest Rates: - Synchrony (SYF) down 9.1% - Capital One (COF) down 7.4% - Citi (C) down 3.7% - American Express (AXP) down 3.7% - JPMorgan (JPM) down 2.2% Currently Also Lower: - Abercrombie & Fitch (ANF) down 17.9% after narrowing its FY25 guidance - UnitedHealth (UNH) down 0.5% after The Wall Street Journal reported that the company used aggressive tactics to collect payment-boosting diagnoses for Medicare Advantage members
0 · Reply
TheDizPlinTrader
TheDizPlinTrader Jan. 12 at 1:59 PM
$SLNO 💊 1 Hour Levels Price: $44.50 Support: $42.90 Resistance: $46.10 👉 Tap follow to keep these 1-hour levels on your feed.
0 · Reply
Baldchinese
Baldchinese Jan. 12 at 1:24 PM
$SLNO no brainer buy at this levels
1 · Reply
NiceBuzz
NiceBuzz Jan. 12 at 12:56 PM
$SLNO It’s the trajectory of the launch. I don’t expect you to know that based on your low iq.
1 · Reply
Hottehueh
Hottehueh Jan. 12 at 12:32 PM
$SLNO bought this
0 · Reply
DLAT94
DLAT94 Jan. 12 at 12:30 PM
$SLNO interesting to see, what will happen - they beat consensus again, third time in a row. Almost 100m revenue puts them on the level of other very successful launches of companies. Other metrics might drag the stock down or stall any increase, but how can anyone doubt that this is will be a billion dollar drug in a pretty short time? with courtesy of @Night_Owl_Biotech:
1 · Reply